In a groundbreaking move, President Trump has forged agreements with major pharmaceutical companies to significantly lower drug prices for Americans, ensuring access to affordable medications for chronic conditions.
In a groundbreaking move, President Trump has issued an executive order aimed at ending the price discrimination faced by American consumers in the pharmaceutical market. This order seeks to ensure that Americans pay the same low prices for medications as those in other developed nations, addressing the long-standing issue of subsidizing global pharmaceutical profits.